What drove the PA8.F stock spike in pre-market trading?

The PA8.F stock spike came on higher volume of **7,211** shares and momentum buying ahead of the 02 Apr 2026 earnings window. Thin average volume magnified the move, and small-cap healthcare names often react strongly to speculative flows.

How does Meyka AI rate PA8.F and what does the grade mean?

Meyka AI rates PA8.F **63.04/100**, Grade B, suggestion HOLD. The grade weighs benchmark and sector comparisons, financial growth, key metrics, and consensus. It signals mixed fundamentals with momentum present.

What are realistic near-term price targets for PA8.F stock?

For short-term traders, a tactical target near **€0.20** is reasonable. Meyka AI’s 12-month model-based target is **€1.29**, implying larger upside if clinical or licensing catalysts arrive. Forecasts are model projections, not guarantees.

Is PA8.F stock liquid enough for larger trades?

No. PA8.F’s average volume is **2,162** shares. Today’s **7,211** volume was elevated, but liquidity remains low, raising execution and slippage risk for large orders. Size positions accordingly.

DE Stocks

PA8.F Paion AG on XETRA pre-market: €0.1095 after 56.43% jump, top gainer insight

ByHuzaifa Zahoor March 3, 2026

Paion AG (PA8.F) jumped in pre-market on XETRA on 03 Mar 2026 to €0.1095, a 56.43% move that placed the name among Germany’s top gainers. The PA8.F stock surge came on 7,211 shares traded versus a 2,162 average, driving market cap to roughly €781,140.00. Early session activity follows short-term momentum versus the 50-day average of €0.02 and 200-day average of €0.01. We examine valuation, technicals, catalysts, and forecasts for PA8.F stock in this pre-market update.